Predictions
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.20
14.10.20
14.10.20
€8.00
04.11.21
04.11.21
181.22%
05.11.21
05.11.21
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€126.00
14.10.20
14.10.20
€120.00
16.10.20
16.10.20
-0.76%
16.10.20
16.10.20
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Editas Medicine Inc
Start price
Target price
Perf. (%)
€27.82
13.10.20
13.10.20
€24.30
04.11.21
04.11.21
-6.72%
04.11.20
04.11.20
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€23.20
13.10.20
13.10.20
€19.20
04.11.21
04.11.21
-28.28%
22.12.20
22.12.20
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.76
13.10.20
13.10.20
€2.90
28.10.20
28.10.20
-8.43%
28.10.20
28.10.20
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Arovella Therapeutics Ltd.
Start price
Target price
Perf. (%)
€0.026
13.10.20
13.10.20
€0.045
04.11.21
04.11.21
-25.77%
05.11.21
05.11.21
Redhill Biopharma Ltd ADR
Start price
Target price
Perf. (%)
€8.60
13.10.20
13.10.20
€10.00
04.11.21
04.11.21
-43.26%
05.11.21
05.11.21
Bastide Le Confort
Start price
Target price
Perf. (%)
€45.70
11.10.20
11.10.20
€48.00
04.11.21
04.11.21
-7.11%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Onxeo S.A.
Start price
Target price
Perf. (%)
€0.64
11.10.20
11.10.20
€0.80
04.11.21
04.11.21
-23.46%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
MyMD Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€3.96
10.10.20
10.10.20
€5.00
04.11.21
04.11.21
102.02%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€54.11
09.10.20
09.10.20
€59.00
04.11.21
04.11.21
6.52%
05.11.21
05.11.21